Pacifica Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4K Hold
230
﹤0.01% 285
2026
Q1
$13.9K Hold
230
﹤0.01% 286
2025
Q4
$12.3K Hold
230
0.01% 283
2025
Q3
$10.9K Hold
230
﹤0.01% 320
2025
Q2
$10.7K Sell
230
-30
-12% -$1.47K ﹤0.01% 330
2025
Q1
$15K Hold
260
0.01% 303
2024
Q4
$14.8K Sell
260
-560
-68% -$31.3K 0.01% 312
2024
Q3
$42.4K Sell
820
-145
-15% -$6.8K 0.02% 219
2024
Q2
$38.6K Sell
965
-62,672
-98% -$2.8M 0.02% 232
2024
Q1
$3.32M Sell
63,637
-658
-1% -$33.5K 1.47% 25
2023
Q4
$3.23M Sell
64,295
-399
-0.6% -$20.9K 1.59% 19
2023
Q3
$3.65M Sell
64,694
-199
-0.3% -$12.2K 1.99% 14
2023
Q2
$4.2M Buy
64,893
+6,816
+12% +$457K 2.38% 11
2023
Q1
$4.09M Buy
58,077
+10,476
+22% +$739K 2.46% 8
2022
Q4
$3.46M Buy
47,601
+6,120
+15% +$461K 2.35% 11
2022
Q3
$2.73M Sell
41,481
-550
-1% -$39.9K 1.98% 14
2022
Q2
$3.36M Sell
42,031
-694
-2% -$52.9K 2.32% 9
2022
Q1
$2.94M Sell
42,725
-3,743
-8% -$251K 1.91% 13
2021
Q4
$2.92M Buy
46,468
+766
+2% +$44.9K 1.91% 14
2021
Q3
$2.75M Buy
45,702
+1,646
+4% +$108K 2% 14
2021
Q2
$2.92M Buy
44,056
+1,335
+3% +$87K 2.21% 11
2021
Q1
$2.68M Buy
42,721
+4,916
+13% +$306K 2.21% 11
2020
Q4
$2.31M Buy
+37,805
New +$2.32M 2.23% 11

Other funds holding BMY

Pacifica Partners's BMY Position: Q2 2026 in Review

Pacifica Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 230 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Pacifica Partners first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.2M in Q2 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pacifica Partners held 230 shares of Bristol-Myers Squibb worth $13.4K as of Q2 2026.
  • Pacifica Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #285 holding.
  • Pacifica Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Pacifica Partners's Bristol-Myers Squibb position peaked at $4.2M in Q2 2023.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.